Treatment successfully delivers drug across the blood-brain barrier directly to brain tumor in mice
- Glioblastoma currently has no cure. New treatments urgently needed
- Powerful drug is 1,400 times more potent than current treatment against the brain tumor
- Scientists applying to FDA for approval to test this novel treatment in patients with recurrent glioblastoma
One of most potent drugs for treatment of glioblastoma, the most deadly type of brain tumor, can’t be used in patients because of two problems. First, it can’t reach its target because it’s blocked by the blood-brain barrier, a microscopic structure that protects the brain from toxins in the blood. And the conventional formulation for this drug is toxic to the brain.
But now Northwestern Medicine scientists have used a novel technology for opening the blood-brain barrier with an implantable ultrasound, and have delivered the powerful drug to the tumor in mice. In a new paper, they report on their findings of extensive preclinical research.
The scientists also discovered brain toxicity for the conventional formulation for this drug – paclitaxel -to the brain was caused by the solution required to dissolve the drug (cremophor.) Scientists tested a new formulation of the drug that uses albumin as opposed to cremophor, and it was not harmful to the brain.
Opening of the blood-brain barrier with an ultrasound increased the concentrations of this paclitaxel in the brain by five-fold. The study also showed that the brain tumor-bearing mice live much longer when treated with the powerful cancer-fighting drug paclitaxel, and survival was even further extended when treated in combination with ultrasound to open the blood-brain barrier.
The study will be published Dec. 12 inĀ Clinical Cancer Research, a journal of the American Association for Cancer Research.
In the laboratory, paclitaxel is much more potent than the currently used chemotherapy temozolomide. When paclitaxel was tested against the brain tumor in a dish outside an organism, a 1,400-fold lesser drug concentration was necessary to kill same number of tumor cells, compared to the conventional chemotherapy used for this cancer.
The scientists are now applying to the U.S. Food & Drug Administration to launch a clinical trial to test this concept of a new formulation of paclitaxel in combination with the novel ultrasound technology to open the blood-brain barrier in patients. The planned trial aims to determine if the treatment is safe, and if it prolongs survival of patients with brain cancer.
“Glioblastoma currently has no cure, and when the tumor recurs there are not many treatment options,” said the principal investigator for this study, Dr. Adam Sonabend, an assistant professor of neurological surgery at Northwestern University Feinberg School of Medicine and a Northwestern Medicine physician. “We urgently need effective new treatments.”
The ultrasound technology may have broader benefits. “This ultrasound technology now will enable us to use many agents established in other cancers for patients with brain tumors,” said co-investigator Roger Stupp, chief of neuro-oncology and the Paul C. Bucy Professor of Neurological Surgery at Feinberg.
Other clinical trials are testing ultrasound-based opening of the blood brain barrier with various chemotherapy agents, but none are using such a potent drug as paclitaxel.
How does it work?
The tiny ultrasound would be implanted during surgery into a window in the skull that does not contain bone. It is used in combination with microscopic gas bubbles injected into the blood at the same time the ultrasound begins. When the bubbles hit the sound waves, these vibrate and mechanically disrupt the blood-brain barrier. The opening is immediate, allowing penetration of the drug molecules. The blood-brain barrier opening is reversible and lasts for several hours after the sonication. The ultrasound emitter remains in the skull for repeated delivery of the drug.
Learn more: Ultrasound blasts potent glioblastoma drug into brain tumor
Go deeper with Bing News on:
Glioblastoma
- Vogt's Notes: I miss my friend and our early morning walks
Today, I miss our walks. I miss my friend. I'm beyond grateful for the many years of friendship we had. You may recall a column I wrote in November about the bingo words I chose for a virtual game we ...
- Join WSB-TV as we race in Jovita Moore’s memory, support brain tumor patients and families on May 11
The National Brain Tumor Society is hosting a 5K walk/run to raise awareness and funds to support the needs of brain tumor patients and their families.
- Glioblastoma Pipeline Landscape Report 2024: Pivotal Advances in Treatment Protocols and Drug Developments
The "Glioblastoma - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The latest report on the Glioblastoma pipeline insights covers extensive research into the ...
- New Therapy Destroys Deadly Brain Tumor in Days
A groundbreaking new therapy destroys deadly brain tumors within days. The new treatment, CAR T-cell therapy, helps treat glioblastoma.
- Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas with MET Fusion Gene
Apollomics’ partner in China, Avistone, received approval from National Medical Products Administration of China to expand the use of vebreltinib to the treatment of gliomas with PTPRZ1-MET fusion ...
Go deeper with Google Headlines on:
Glioblastoma
[google_news title=”” keyword=”glioblastoma” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Ultrasound
- Pivotal roundtable focuses on ultrasound training and certification for primary maternal health clinicians
Inteleos is set to host a pivotal roundtable alongside a side event during the WHO World Health Assembly and the AI for Good Global Summit.
- Caitlin Clark Signs One of the Oddest Possible Items for a Fan — Their Ultrasound!
Caitlin Clark was a fan favorite when she attended the Indiana Pacers' playoff game on Friday night, with one woman asking the new WNBA star to sign an ultrasound printout ...
- Two Women Born with a Double Uterus Welcome Twins in the Same Hospital: 'One in a Million'
After two past miscarriages, Pascoe and her husband John learned they were pregnant with twins during their first ultrasound appointment. "I remember the ultrasound technician kind of doing a ...
- HIFU heat and ultrasound target prostate cancer without surgery
The procedure avoids surgery by using ultrasound waves, imaging, heat, and algorithms to destroy prostate cancer tissue with far less chance of side effects.
- WNBA star Caitlin Clark autographs ultrasound photo during appearance at Pacers playoff game
The excitement for Caitlin Clark's upcoming WNBA debut continues to build, to the point she is receiving requests to sign ultrasound images.
Go deeper with Google Headlines on:
Ultrasound
[google_news title=”” keyword=”ultrasound” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]